• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神科评定工具的评分者评估与文化差异:中国和美国的阳性与阴性症状量表

Rater evaluations for psychiatric instruments and cultural differences: the positive and negative syndrome scale in China and the United States.

作者信息

Aggarwal Neil Krishan, Zhang Xiang Yang, Stefanovics Elina, Chen Da Chun, Xiu Mei Hong, Xu Ke, Rosenheck Robert A

机构信息

Department of Psychiatry, Yale University, New Haven, CT, USA.

出版信息

J Nerv Ment Dis. 2012 Sep;200(9):814-20. doi: 10.1097/NMD.0b013e318266bcaa.

DOI:10.1097/NMD.0b013e318266bcaa
PMID:22922237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3885177/
Abstract

This article compares Positive and Negative Syndrome Scale (PANSS) data from Chinese and American inpatients with chronic schizophrenia to show how differences in item ratings may reflect cultural attitudes of raters. The Chinese sample (N = 504) came from Beijing Huilongguan Hospital. The American sample came from 268 PANSS assessments of Clinical Antipsychotic Trials of Intervention Effectiveness subjects hospitalized for 15 days or more to optimize equivalence of the samples. When controlling for age and sex, the Chinese sample scored significantly lower for total score by 25% (p < 0.0001), for the positive subscale by 35% (p < 0.0001), and on the general subscale by 32% (p < 0.0001) but not significantly different on the negative subscale score (+0.26%; p = 0.76). However, the Chinese sample scored 26% higher on the item on poor rapport (p < 0.0001), 10.2% higher on passive social withdrawal (p = 0.003), and most notably 46% higher on the item on lack of judgment and insight (p < 0.0001). These results remain broadly consistent across sex subgroup analyses. Differences seem to be best explained by both cultural differences in patient clinical presentations and varying American and Chinese cultural values affecting rater judgment.

摘要

本文比较了中国和美国慢性精神分裂症住院患者的阳性与阴性症状量表(PANSS)数据,以展示条目评分差异如何反映评分者的文化态度。中国样本(N = 504)来自北京回龙观医院。美国样本来自对干预有效性临床抗精神病药物试验中住院15天或更长时间的受试者进行的268次PANSS评估,以优化样本的等效性。在控制年龄和性别后,中国样本的总分显著低25%(p < 0.0001),阳性分量表低35%(p < 0.0001),一般分量表低32%(p < 0.0001),但阴性分量表得分无显著差异(+0.26%;p = 0.76)。然而,中国样本在关系不良条目上得分高26%(p < 0.0001),在被动社交退缩条目上高10.2%(p = 0.003),最显著的是在缺乏判断力和洞察力条目上高46%(p < 0.0001)。这些结果在性别亚组分析中大体保持一致。差异似乎最好由患者临床表现的文化差异以及影响评分者判断的中美文化价值观差异来解释。

相似文献

1
Rater evaluations for psychiatric instruments and cultural differences: the positive and negative syndrome scale in China and the United States.精神科评定工具的评分者评估与文化差异:中国和美国的阳性与阴性症状量表
J Nerv Ment Dis. 2012 Sep;200(9):814-20. doi: 10.1097/NMD.0b013e318266bcaa.
2
Comparing the PANSS in Chinese and American inpatients: cross-cultural psychiatric analyses of instrument translation and implementation.比较中美住院患者的 PANSS:工具翻译和实施的跨文化精神病学分析。
Schizophr Res. 2011 Nov;132(2-3):146-52. doi: 10.1016/j.schres.2011.08.003. Epub 2011 Sep 1.
3
Inter-rater reliability of ratings on the six-item Positive and Negative Syndrome Scale (PANSS-6) obtained using the Simplified Negative and Positive Symptoms Interview (SNAPSI).使用简化正负症状访谈(SNAPSI)获得的六项阳性和阴性症状量表(PANSS-6)评分的评分者间信度。
Nord J Psychiatry. 2018 Aug;72(6):431-436. doi: 10.1080/08039488.2018.1492014. Epub 2018 Jul 24.
4
Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.《卡尔加里精神分裂症抑郁量表西班牙语版的跨文化改编与验证》
Schizophr Res. 2004 Jun 1;68(2-3):349-56. doi: 10.1016/S0920-9964(02)00490-5.
5
Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.在常规临床实践中,使用抗精神病药物治疗精神分裂症谱系障碍门诊患者的阴性症状患病率:CLAMORS 研究的结果。
J Clin Psychiatry. 2010 Mar;71(3):280-6. doi: 10.4088/JCP.08m04250yel. Epub 2009 Nov 3.
6
Assessing the sources of unreliability (rater, subject, time-point) in a failed clinical trial using items of the Positive and Negative Syndrome Scale (PANSS).评估一项失败的临床试验中不可靠的来源(评估者、受试者、时间点),使用阳性和阴性症状量表(PANSS)的项目。
J Clin Psychopharmacol. 2013 Feb;33(1):109-17. doi: 10.1097/JCP.0b013e3182776ebe.
7
Item response analysis of the Positive and Negative Syndrome Scale.阳性和阴性症状量表的项目反应分析
BMC Psychiatry. 2007 Nov 15;7:66. doi: 10.1186/1471-244X-7-66.
8
The Greek version of the calgary depression scale for schizophrenia.精神分裂症卡尔加里抑郁量表希腊语版本。
Psychiatry Res. 2000 May 15;94(2):163-71. doi: 10.1016/s0165-1781(00)00137-2.
9
A rasch model to test the cross-cultural validity in the positive and negative syndrome scale (PANSS) across six geo-cultural groups.一个用于检验跨文化效标效度的 Rasch 模型:以六个地理文化群体为对象的阳性与阴性症状量表(PANSS)。
BMC Psychol. 2013 Mar 11;1(1):5. doi: 10.1186/2050-7283-1-5. eCollection 2013.
10
How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS.精神分裂症的阴性症状和认知障碍有多具特异性?对阳性和阴性症状量表及精神分裂症认知功能评定量表的分析
Cogn Neuropsychiatry. 2013 May;18(3):243-51. doi: 10.1080/13546805.2012.730995. Epub 2012 Nov 12.

引用本文的文献

1
COSMIN systematic review and meta-analysis of the measurement properties of the Positive and Negative Syndrome Scale (PANSS).COSMIN对阳性和阴性症状量表(PANSS)测量属性的系统评价与Meta分析。
EClinicalMedicine. 2025 Apr 11;82:103155. doi: 10.1016/j.eclinm.2025.103155. eCollection 2025 Apr.
2
Relationships between smartphone social behavior and relapse in schizophrenia: A preliminary report.智能手机社交行为与精神分裂症复发的关系:初步报告。
Schizophr Res. 2019 Jun;208:167-172. doi: 10.1016/j.schres.2019.03.014. Epub 2019 Mar 30.
3
A rasch model to test the cross-cultural validity in the positive and negative syndrome scale (PANSS) across six geo-cultural groups.一个用于检验跨文化效标效度的 Rasch 模型:以六个地理文化群体为对象的阳性与阴性症状量表(PANSS)。
BMC Psychol. 2013 Mar 11;1(1):5. doi: 10.1186/2050-7283-1-5. eCollection 2013.
4
Insight and attitudes towards medication among inpatients with chronic schizophrenia in the US and China.美国和中国慢性精神分裂症住院患者对药物治疗的认知与态度
Soc Psychiatry Psychiatr Epidemiol. 2014 Jul;49(7):1063-70. doi: 10.1007/s00127-014-0824-1. Epub 2014 Feb 19.

本文引用的文献

1
Self and narrative in schizophrenia: time to author a new story.精神分裂症中的自我与叙事:是时候创作一个新故事了。
Med Humanit. 2005 Dec;31(2):89-94. doi: 10.1136/jmh.2005.000214.
2
Comparing the PANSS in Chinese and American inpatients: cross-cultural psychiatric analyses of instrument translation and implementation.比较中美住院患者的 PANSS:工具翻译和实施的跨文化精神病学分析。
Schizophr Res. 2011 Nov;132(2-3):146-52. doi: 10.1016/j.schres.2011.08.003. Epub 2011 Sep 1.
3
Cross-ethnic differences in severity of symptomatology of individuals with first-episode schizophrenia spectrum disorder.首发精神分裂谱系障碍患者症状严重程度的跨民族差异。
Early Interv Psychiatry. 2011 Aug;5(3):242-8. doi: 10.1111/j.1751-7893.2011.00260.x. Epub 2011 Mar 30.
4
Developing a policy for second-generation antipsychotic drugs.制定第二代抗精神病药物政策。
Health Aff (Millwood). 2009 Sep-Oct;28(5):w782-93. doi: 10.1377/hlthaff.28.5.w782. Epub 2009 Jul 21.
5
The efficacy and safety of blonanserin compared with haloperidol in acute-phase schizophrenia: a randomized, double-blind, placebo-controlled, multicentre study.急性期精神分裂症中,布南色林与氟哌啶醇相比的疗效和安全性:一项随机、双盲、安慰剂对照、多中心研究。
CNS Drugs. 2009;23(7):615-25. doi: 10.2165/00023210-200923070-00006.
6
Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia.中国精神分裂症患者中迟发性运动障碍的患病率、风险及临床相关性的性别差异
Psychopharmacology (Berl). 2009 Sep;205(4):647-54. doi: 10.1007/s00213-009-1590-8. Epub 2009 Jun 16.
7
Switching to aripiprazole in outpatients with schizophrenia experiencing insufficient efficacy and/or safety/tolerability issues with risperidone: a randomized, multicentre, open-label study.对于使用利培酮疗效欠佳和/或存在安全性/耐受性问题的精神分裂症门诊患者,换用阿立哌唑的随机、多中心、开放标签研究。
Pharmacopsychiatry. 2009 May;42(3):114-21. doi: 10.1055/s-0028-1112134. Epub 2009 May 18.
8
Neurological soft signs in patients with schizophrenia and their unaffected siblings: frequency and correlates in two ethnic and socioeconomic distinct populations.精神分裂症患者及其未患病同胞的神经软体征:两个不同种族和社会经济群体中的发生率及其相关因素
Eur Arch Psychiatry Clin Neurosci. 2009 Jun;259(4):218-26. doi: 10.1007/s00406-008-0859-y. Epub 2009 Feb 17.
9
"Excessive thinking" as explanatory model for schizophrenia: impacts on stigma and "moral" status in Mainland China.“过度思考”作为精神分裂症的解释模型:对中国大陆污名化和“道德”地位的影响。
Schizophr Bull. 2010 Jul;36(4):836-45. doi: 10.1093/schbul/sbn180. Epub 2009 Feb 4.
10
A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia.一项口服阿立哌唑治疗青少年精神分裂症的多中心、随机、双盲、安慰剂对照研究。
Am J Psychiatry. 2008 Nov;165(11):1432-41. doi: 10.1176/appi.ajp.2008.07061035. Epub 2008 Sep 2.